A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

NCT03833700 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Neoplasms
Colorectal Neoplasms
Gastrointestinal Tumors

Interventions

DRUG: E7386

Sponsor

Eisai Co., Ltd.